Ibaraki, Japan

Michio Nakai


Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 35(Granted Patents)


Location History:

  • Osaka, JP (1997)
  • Ibaraki, JP (2008 - 2013)

Company Filing History:


Years Active: 1997-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michio Nakai: Innovator in Gene Therapy

Introduction

Michio Nakai is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of gene therapy, particularly through his work on adenovirus vectors. With a total of 3 patents, Nakai's innovations are paving the way for advancements in medical treatments.

Latest Patents

One of Nakai's latest patents is a recombinant adenovirus vector designed to reduce side effects during in vivo administration. This novel vector alleviates inflammation by inhibiting the expression of an adenovirus gene through a foreign promoter inserted into the adenovirus genome. Additionally, he has developed methods for producing this vector, along with a cell line for its production and a gene therapy method utilizing the recombinant adenovirus vector.

Career Highlights

Throughout his career, Michio Nakai has worked with notable companies such as Dainippon Sumitomo Pharma Co., Ltd. and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has contributed to his expertise in the field of pharmaceuticals and gene therapy.

Collaborations

Nakai has collaborated with esteemed colleagues, including Izumu Saito and Kazuo Komiya. These partnerships have further enhanced his research and development efforts in innovative medical solutions.

Conclusion

In summary, Michio Nakai is a distinguished inventor whose work in gene therapy is making a significant impact in the medical field. His innovative approaches and collaborations are essential for the advancement of effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…